Pricing Log in Create free account
Saturday 17 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.71 0.86 −1.42%
Market cap
$123.7B
P/E
13.2×
Fwd P/E
11.2×
Dividend yield
4.22%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bristol Myers Squibb Company (BMY) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Bristol Myers Squibb Company (BMY) trades at a P/B ratio of 5.5×. Over the past ten years it has ranged from 1.5× (March 2020) to 9.6× (February 2018); the current reading is higher than 49% of that period. That is above the Drug Manufacturers General industry median of 5.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 5.9× (15.25%)
FY2024 7.0× 88.96%
FY2023 3.7× (25.15%)
FY2022 4.9× 28.60%
FY2021 3.8× 4.02%
FY2020 3.7× 74.65%
FY2019 2.1× (64.77%)
FY2018 6.0× (29.42%)
FY2017 8.5× 40.09%
FY2016 6.1× (23.56%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 5.3× (14.26%)
Mar 2026 6.1× 3.71%
Dec 2025 5.9× 20.09%
Sep 2025 4.9× (8.33%)
42 more quarters

Against its own ten years

Low 1.5× High 9.6×
Ten-year median 5.5×
Current reading's percentile 53

P/B ratio against peers

Company P/B ratio
SNY Sanofi compare 1.2×
PFE Pfizer Inc. compare 2.0×
GSK GSK PLC Sponsored ADR compare 4.3×
NVO Novo Nordisk A/S compare 5.0×
AZN AstraZeneca PLC compare 5.1×
BMY Bristol Myers Squibb Company 5.5×
NVS Novartis AG compare 6.8×
GILD Gilead Sciences, Inc. compare 16.5×
AMGN Amgen Inc. compare 20.0×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on BMY